Company intelligence / Profile preview
Acousia Therapeutics GmbH
Tübingen, Baden-Württemberg, Germanyacousia.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Acousia Therapeutics has advanced its lead candidate ACOU085 into Phase II clinical trials for prevention of cisplatin-induced ototoxicity and age-related hearing loss. In completed Phase I studies, ACOU085 demonstrated excellent safety, tolerability, and long local residence time. The ongoing PROHEAR study evaluates efficacy in preventing chemotherapy-induced hearing damage; next-generation candidates are also progressing through preclinical development.
- Therapeutic areas
- OtherOncologyNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Exclusive collaboration with Translational Hearing Research Group at Tuebingen University ClinicBoehringer Ingelheim Venture Fund as lead investor/board representation
Beyond the preview
Go deeper on Acousia Therapeutics GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acousia Therapeutics GmbH.